Host restriction of Escherichia coli recurrent urinary tract infection occurs in a bacterial strain-specific manner

Strains of bacterial species induce a greatly varied acute adaptive immune response: The contribution of the accessory genome

(2018) Uri Sela et al.   PLoS Pathogens

Catheterization alters bladder ecology to potentiateStaphylococcus aureusinfection of the urinary tract

(2017) Jennifer N. Walker et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Transient microbiota exposures activate dormant Escherichia coli infection in the bladder and drive severe outcomes of recurrent disease

(2017) Nicole M. Gilbert et al.   PLoS Pathogens

Escherichia coli Harboringmcr-1andblaCTX-Mon a Novel IncF Plasmid: First Report ofmcr-1in the United States

(2016) Patrick McGann et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

A mucosal imprint left by prior Escherichia coli bladder infection sensitizes to recurrent disease

(2016) Valerie P. O'Brien et al.   Nature Microbiology

dsdA Does Not Affect Colonization of the Murine Urinary Tract by Escherichia coli CFT073

(2015) Andrew J. Hryckowian et al.   PLoS One

Macrophages Subvert Adaptive Immunity to Urinary Tract Infection

(2015) Gabriela Mora-Bau et al.   PLoS Pathogens

CD4+ T Cells: Guardians of the Phagosome

(2014) N. J. Tubo et al.   CLINICAL MICROBIOLOGY REVIEWS

Impact of Host Age and Parity on Susceptibility to Severe Urinary Tract Infection in a Murine Model

(2014) Kimberly A. Kline et al.   PLoS One

Inhibition of Cyclooxygenase-2 Prevents Chronic and Recurrent Cystitis

(2014) Thomas J. Hannan et al.   EBioMedicine

Mast Cell Interleukin-10 Drives Localized Tolerance in Chronic Bladder Infection

(2013) Cheryl Y. Chan et al.   IMMUNITY

Positively selected FimH residues enhance virulence during urinary tract infection by altering FimH conformation

(2013) D. J. Schwartz et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

From Physiology to Pharmacy: Developments in the Pathogenesis and Treatment of Recurrent Urinary Tract Infections

(2013) Jennifer A. Silverman et al.   Current Urology Reports

Estimating variation within the genes and inferring the phylogeny of 186 sequenced diverse Escherichia coli genomes

(2012) Rolf S Kaas et al.   BMC GENOMICS

Symptomatic treatment (ibuprofen) or antibiotics (ciprofloxacin) for uncomplicated urinary tract infection? - Results of a randomized controlled pilot trial

(2010) Jutta Bleidorn et al.   BMC Medicine

Lung CD4-CD8- Double-Negative T Cells Are Prominent Producers of IL-17A and IFN-  during Primary Respiratory Murine Infection with Francisella tularensis Live Vaccine Strain

(2010) S. C. Cowley et al.   JOURNAL OF IMMUNOLOGY

The Innate Immune Response to Uropathogenic Escherichia coli Involves IL-17A in a Murine Model of Urinary Tract Infection

(2010) Kelsey E. Sivick et al.   JOURNAL OF IMMUNOLOGY

The epidemiology of urinary tract infection

(2010) Betsy Foxman   Nature Reviews Urology

Early Severe Inflammatory Responses to Uropathogenic E. coli Predispose to Chronic and Recurrent Urinary Tract Infection

(2010) Thomas J. Hannan et al.   PLoS Pathogens

A murine model of urinary tract infection

(2009) Chia-Suei Hung et al.   Nature Protocols

Origins and virulence mechanisms of uropathogenic Escherichia coli

(2008) Travis J. Wiles et al.   EXPERIMENTAL AND MOLECULAR PATHOLOGY